REACH: C—cause

• by Stephanie Williams, Laween Meran, Sara McCartney, Paul Harrow, James C Lee

• January 27, 2026

Exploring Comorbidity Patterns in Inflammatory Bowel Disease: Insights from the All of Us Research Program

• by Soham C. Sudhakaran, Matthew T. Wayland, Yogesh Purushotham, Scott B. Minchenberg, Kanwal Bains, Sudhakaran Prabakaran

• March 14, 2026

The Oral Microbiome's Role: Linking Periodontal Dysbiosis to Systemic Health Issues

• by Wenqin Jin, Lichao Tang, Jiaqi Yang, Xianlong Hu, Weiwei Guo, Huangping Ai, Yuling Zuo, Zhao Jin

• April 29, 2026

This Week’s Biopharma News: Amgen Deepens US Manufacturing Push

The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production

• May 12, 2026

• 7 min